ONCODESIGN: Resilient performance from the Service BU in 1H but 2020 guidance is at risk | CORPORATE | EUR15
ONCODESIGN - CORPORATE | EUR15Resilient performance from the Service BU in 1H but 2020 guidance is at risk
Our cautious approach to Service BU sales has paid off
Good surprises should come from the Pharma BU
EUR15 FV confirmed with free upsides on the table
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.